European Journal of Cancer
Volume 41, Issue 17 , Pages 2620-2629 , November 2005

The Notch pathway in cancer: Differentiation gone awry

Received 31 March 2005 ,Accepted 6 June 2005.

References 

  1. Morgan T. The theory of the gene. Am Nat. 1917;51:513–544
  2. Artavanis-Tsakonas S, Rand MD, Lake RJ. Notch signaling: cell fate control and signal integration in development. Science. 1999;284(5415):770–776
  3. Ellisen LW, Bird J, West DC, et al. TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell. 1991;66(4):649–661
  4. Lai EC. Notch signaling: control of cell communication and cell fate. Development. 2004;131(5):965–973
  5. Mumm JS, Kopan R. Notch signaling: from the outside in. Dev Biol. 2000;228(2):151–165
  6. Kadesch T. Notch signaling: the demise of elegant simplicity. Curr Opin Genet Dev. 2004;14(5):506–512
  7. Hansson EM, Lendahl U, Chapman G. Notch signaling in development and disease. Semin Cancer Biol. 2004;14(5):320–328
  8. Logeat F, Bessia C, Brou C, et al. The Notch1 receptor is cleaved constitutively by a furin-like convertase. Proc Natl Acad Sci USA. 1998;95(14):8108–8112
  9. Gupta-Rossi N, Le Bail O, Gonen H, et al. Functional interaction between SEL-10, an F-box protein, and the nuclear form of activated Notch1 receptor. J Biol Chem. 2001;276(37):34371–34378
  10. Brou C, Logeat F, Gupta N, et al. A novel proteolytic cleavage involved in Notch signaling: the role of the disintegrin-metalloprotease TACE. Mol Cell. 2000;5(2):207–216
  11. Mumm JS, Schroeter EH, Saxena MT, et al. A ligand-induced extracellular cleavage regulates γ-secretase-like proteolytic activation of Notch1. Mol Cell. 2000;5(2):197–206
  12. Fortini ME. Gamma-secretase-mediated proteolysis in cell-surface-receptor signalling. Nat Rev Mol Cell Biol. 2002;3(9):673–684
  13. Hsieh JJ, Zhou S, Chen L, et al. CIR, a co-repressor linking the DNA binding factor CBF1 to the histone deacetylase complex. Proc Natl Acad Sci USA. 1999;96(1):23–28
  14. Jarriault S, Brou C, Logeat F, et al. Signalling downstream of activated mammalian Notch. Nature. 1995;377(6547):355–358
  15. Kao HY, Ordentlich P, Koyano-Nakagawa N, et al. A histone deacetylase co-repressor complex regulates the Notch signal transduction pathway. Genes Dev. 1998;12(15):2269–2277
  16. Fryer CJ, White JB, Jones KA. Mastermind recruits CycC:CDK8 to phosphorylate the Notch ICD and coordinate activation with turnover. Mol Cell. 2004;16(4):509–520
  17. Wu L, Aster JC, Blacklow SC, et al. MAML1, a human homologue of Drosophila mastermind, is a transcriptional co-activator for NOTCH receptors. Nat Genet. 2000;26(4):484–489
  18. Wu L, Sun T, Kobayashi K, et al. Identification of a family of mastermind-like transcriptional co-activators for mammalian notch receptors. Mol Cell Biol. 2002;22(21):7688–7700
  19. Nickoloff BJ, Osborne BA, Miele L. Notch signaling as a therapeutic target in cancer: a new approach to the development of cell fate modifying agents. Oncogene. 2003;22(42):6598–6608
  20. Iso T, Kedes L, Hamamori Y. HES and HERP families: multiple effectors of the Notch signaling pathway. J Cell Physiol. 2003;194(3):237–255
  21. Ju BG, Solum D, Song EJ, et al. Activating the PARP-1 sensor component of the groucho/ TLE1 co-repressor complex mediates a CaMKinase IIdelta-dependent neurogenic gene activation pathway. Cell. 2004;119(6):815–829
  22. de la Pompa JL, Wakeham A, Correia KM, et al. Conservation of the Notch signalling pathway in mammalian neurogenesis. Development. 1997;124(6):1139–1148
  23. Pear WS, Aster JC. T cell acute lymphoblastic leukemia/lymphoma: a human cancer commonly associated with aberrant NOTCH1 signaling. Curr Opin Hematol. 2004;11(6):426–433
  24. Pui JC, Allman D, Xu L, et al. Notch1 expression in early lymphopoiesis influences B versus T lineage determination. Immunity. 1999;11(3):299–308
  25. Radtke F, Wilson A, Stark G, et al. Deficient T cell fate specification in mice with an induced inactivation of Notch1. Immunity. 1999;10(5):547–558
  26. Ciofani M, Schmitt TM, Ciofani A, et al. Obligatory role for cooperative signaling by pre-TCR and Notch during thymocyte differentiation. J Immunol. 2004;172(9):5230–5239
  27. Allman D, Karnell FG, Punt JA, et al. Separation of Notch1 promoted lineage commitment and expansion/transformation in developing T cells. J Exp Med. 2001;194(1):99–106
  28. Screpanti I, Bellavia D, Campese AF, et al. Notch, a unifying target in T-cell acute lymphoblastic leukemia?. Trends Mol Med. 2003;9(1):30–35
  29. Weng AP, Ferrando AA, Lee W, et al. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science. 2004;306(5694):269–271
  30. Mikkers H, Berns A. Retroviral insertional mutagenesis: tagging cancer pathways. Adv Cancer Res. 2003;88:53–99
  31. Gallahan D, Callahan R. Mammary tumorigenesis in feral mice: identification of a new int locus in mouse mammary tumor virus (Czech II)-induced mammary tumors. J Virol. 1987;61(1):66–74
  32. Jhappan C, Gallahan D, Stahle C, et al. Expression of an activated Notch-related int-3 transgene interferes with cell differentiation and induces neoplastic transformation in mammary and salivary glands. Genes Dev. 1992;6(3):345–355
  33. Gallahan D, Jhappan C, Robinson G, et al. Expression of a truncated Int3 gene in developing secretory mammary epithelium specifically retards lobular differentiation resulting in tumorigenesis. Cancer Res. 1996;56(8):1775–1785
  34. Robbins J, Blondel BJ, Gallahan D, et al. Mouse mammary tumor gene int-3: a member of the notch gene family transforms mammary epithelial cells. J Virol. 1992;66(4):2594–2599
  35. Uyttendaele H, Marazzi G, Wu G, et al. Notch4/int-3, a mammary proto-oncogene, is an endothelial cell-specific mammalian Notch gene. Development. 1996;122(7):2251–2259
  36. Soriano JV, Uyttendaele H, Kitajewski J, et al. Expression of an activated Notch4(int-3) oncoprotein disrupts morphogenesis and induces an invasive phenotype in mammary epithelial cells in vitro. Int J Cancer. 2000;86(5):652–659
  37. Chen Y, Fischer WH, Gill GN. Regulation of the ERBB-2 promoter by RBPJkappa and NOTCH. J Biol Chem. 1997;272(22):14110–14114
  38. Dievart A, Beaulieu N, Jolicoeur P. Involvement of Notch1 in the development of mouse mammary tumors. Oncogene. 1999;18(44):5973–5981
  39. Ronchini C, Capobianco AJ. Induction of cyclin D1 transcription and CDK2 activity by Notch (ic): implication for cell cycle disruption in transformation by Notch (ic). Mol Cell Biol. 2001;21(17):5925–5934
  40. Wang TC, Cardiff RD, Zukerberg L, et al. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature. 1994;369(6482):669–671
  41. Kiaris H, Politi K, Grimm LM, et al. Modulation of notch signaling elicits signature tumors and inhibits hras1-induced oncogenesis in the mouse mammary epithelium. Am J Pathol. 2004;165(2):695–705
  42. Weijzen S, Rizzo P, Braid M, et al. Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells. Nat Med. 2002;8(9):979–986
  43. Pece S, Serresi M, Santolini E, et al. Loss of negative regulation by Numb over Notch is relevant to human breast carcinogenesis. J Cell Biol. 2004;167(2):215–221
  44. Fan X, Mikolaenko I, Elhassan I, et al. Notch1 and notch2 have opposite effects on embryonal brain tumor growth. Cancer Res. 2004;64(21):7787–7793
  45. Hallahan AR, Pritchard JI, Hansen S, et al. The SmoA1 mouse model reveals that notch signaling is critical for the growth and survival of sonic hedgehog-induced medulloblastomas. Cancer Res. 2004;64(21):7794–7800
  46. Dahlenfors R, Wedell B, Rundrantz H, et al. Translocation(11;19)(q14-21;p12) in a parotid mucoepidermoid carcinoma of a child. Cancer Genet Cytogenet. 1995;79(2):188
  47. Johansson M, Mandahl N, Johansson L, et al. Translocation 11;19 in a mucoepidermoid tumor of the lung. Cancer Genet Cytogenet. 1995;80(1):85–86
  48. Horsman DE, Berean K, Durham JS. Translocation (11;19) (q21;p13.1) in mucoepidermoid carcinoma of salivary gland. Cancer Genet Cytogenet. 1995;80(2):165–166
  49. Tonon G, Modi S, Wu L, et al. t (11;19) (q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway. Nat Genet. 2003;33(2):208–213
  50. Jeffries S, Robbins DJ, Capobianco AJ. Characterization of a high-molecular-weight Notch complex in the nucleus of Notch (ic)-transformed RKE cells and in a human T-cell leukemia cell line. Mol Cell Biol. 2002;22(11):3927–3941
  51. Hayward SD. Viral interactions with the Notch pathway. Semin Cancer Biol. 2004;14(5):387–396
  52. Thorley-Lawson DA. Epstein–Barr virus: exploiting the immune system. Nat Rev Immunol. 2001;1(1):75–82
  53. Henkel T, Ling PD, Hayward SD, et al. Mediation of Epstein–Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa. Science. 1994;265(5168):92–95
  54. Waltzer L, Logeat F, Brou C, et al. The human J kappa recombination signal sequence binding protein (RBP-J kappa) targets the Epstein–Barr virus EBNA2 protein to its DNA responsive elements. Embo J. 1994;13(23):5633–5638
  55. Grossman SR, Johannsen E, Tong X, et al. The Epstein–Barr virus nuclear antigen 2 transactivator is directed to response elements by the J kappa recombination signal binding protein. Proc Natl Acad Sci USA. 1994;91(16):7568–7572
  56. Hsieh JJ, Hayward SD. Masking of the CBF1/RBPJ kappa transcriptional repression domain by Epstein–Barr virus EBNA2. Science. 1995;268(5210):560–563
  57. Cooper A, Johannsen E, Maruo S, et al. EBNA3A association with RBP-Jkappa down-regulates c-myc and Epstein–Barr virus-transformed lymphoblast growth. J Virol. 2003;77(2):999–1010
  58. Johannsen E, Miller CL, Grossman SR, et al. EBNA-2 and EBNA-3C extensively and mutually exclusively associate with RBPJkappa in Epstein–Barr virus-transformed B lymphocytes. J Virol. 1996;70(6):4179–4183
  59. Lefort K, Dotto GP. Notch signaling in the integrated control of keratinocyte growth/differentiation and tumor suppression. Semin Cancer Biol. 2004;14(5):374–386
  60. Rae FK, Stephenson SA, Nicol DL, et al. Novel association of a diverse range of genes with renal cell carcinoma as identified by differential display. Int J Cancer. 2000;88(5):726–732
  61. Santagata S, Demichelis F, Riva A, et al. JAGGED1 expression is associated with prostate cancer metastasis and recurrence. Cancer Res. 2004;64(19):6854–6857
  62. Houde C, Li Y, Song L, et al. Overexpression of the NOTCH ligand JAG2 in malignant plasma cells from multiple myeloma patients and cell lines. Blood. 2004;104(12):3697–3704
  63. Jundt F, Anagnostopoulos I, Forster R, et al. Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma. Blood. 2002;99(9):3398–3403
  64. Jundt F, Probsting KS, Anagnostopoulos I, et al. Jagged1-induced Notch signaling drives proliferation of multiple myeloma cells. Blood. 2004;103(9):3511–3515
  65. Miyamoto Y, Maitra A, Ghosh B, et al. Notch mediates TGF alpha-induced changes in epithelial differentiation during pancreatic tumorigenesis. Cancer Cell. 2003;3(6):565–576
  66. Apelqvist A, Li H, Sommer L, et al. Notch signalling controls pancreatic cell differentiation. Nature. 1999;400(6747):877–881
  67. Jensen J, Pedersen EE, Galante P, et al. Control of endodermal endocrine development by Hes-1. Nat Genet. 2000;24(1):36–44
  68. Jensen J, Heller RS, Funder-Nielsen T, et al. Independent development of pancreatic alpha- and beta-cells from neurogenin3-expressing precursors: a role for the notch pathway in repression of premature differentiation. Diabetes. 2000;49(2):163–176
  69. Hruban RH, Wilentz RE, Goggins M, et al. Pathology of incipient pancreatic cancer. Ann Oncol. 1999;10(Suppl 4):9–11
  70. Fitzgerald K, Harrington A, Leder P. Ras pathway signals are required for notch-mediated oncogenesis. Oncogene. 2000;19(37):4191–4198
  71. Ruiz-Hidalgo MJ, Garces C, Laborda J. Notch-1 expression levels in 3T3-L1 cells influence ras signaling and transformation by oncogenic ras. Int J Oncol. 1999;14(4):777–783
  72. Hasson P, Egoz N, Winkler C, et al. EGFR signaling attenuates Groucho-dependent repression to antagonize Notch transcriptional output. Nat Genet. 2005;37(1):101–105
  73. Berset T, Hoier EF, Battu G, et al. Notch inhibition of RAS signaling through MAP kinase phosphatase LIP-1 during C. elegans vulval development. Science. 2001;291(5506):1055–1058
  74. Capobianco AJ, Zagouras P, Blaumueller CM, et al. Neoplastic transformation by truncated alleles of human NOTCH1/TAN1 and NOTCH2. Mol Cell Biol. 1997;17(11):6265–6273
  75. Brodeur GM. Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer. 2003;3(3):203–216
  76. Grynfeld A, Pahlman S, Axelson H. Induced neuroblastoma cell differentiation, associated with transient HES-1 activity and reduced HASH-1 expression, is inhibited by Notch1. Int J Cancer. 2000;88(3):401–410
  77. Persson P, Jogi A, Grynfeld A, et al. HASH-1 and E2-2 are expressed in human neuroblastoma cells and form a functional complex. Biochem Biophys Res Commun. 2000;274(1):22–31
  78. Jogi A, Persson P, Grynfeld A, et al. Modulation of basic helix-loop-helix transcription complex formation by Id proteins during neuronal differentiation. J Biol Chem. 2002;277(11):9118–9126
  79. Jogi A, Ora I, Nilsson H, et al. Hypoxia alters gene expression in human neuroblastoma cells toward an immature and neural crest-like phenotype. Proc Natl Acad Sci USA. 2002;99(10):7021–7026
  80. Jogi A, Vallon-Christersson J, Holmquist L, et al. Human neuroblastoma cells exposed to hypoxia: induction of genes associated with growth, survival, and aggressive behavior. Exp Cell Res. 2004;295(2):469–487
  81. Van Limpt VA, Chan AJ, Van Sluis PG, et al. High delta-like 1 expression in a subset of neuroblastoma cell lines corresponds to a differentiated chromaffin cell type. Int J Cancer. 2003;105(1):61–69
  82. Wei JS, Greer BT, Westermann F, et al. Prediction of clinical outcome using gene expression profiling and artificial neural networks for patients with neuroblastoma. Cancer Res. 2004;64(19):6883–6891
  83. Rangarajan A, Talora C, Okuyama R, et al. Notch signaling is a direct determinant of keratinocyte growth arrest and entry into differentiation. Embo J. 2001;20(13):3427–3436
  84. Nicolas M, Wolfer A, Raj K, et al. Notch1 functions as a tumor suppressor in mouse skin. Nat Genet. 2003;33(3):416–421
  85. Ito T, Udaka N, Yazawa T, et al. Basic helix-loop-helix transcription factors regulate the neuroendocrine differentiation of fetal mouse pulmonary epithelium. Development. 2000;127(18):3913–3921
  86. Chen H, Thiagalingam A, Chopra H, et al. Conservation of the Drosophila lateral inhibition pathway in human lung cancer: a hairy-related protein (HES-1) directly represses achaete-scute homolog-1 expression. Proc Natl Acad Sci USA. 1997;94(10):5355–5360
  87. Ball DW, Azzoli CG, Baylin SB, et al. Identification of a human achaete-scute homolog highly expressed in neuroendocrine tumors. Proc Natl Acad Sci USA. 1993;90(12):5648–5652
  88. Sriuranpong V, Borges MW, Ravi RK, et al. Notch signaling induces cell cycle arrest in small cell lung cancer cells. Cancer Res. 2001;61(7):3200–3205
  89. Garces C, Ruiz-Hidalgo MJ, de Mora JF, et al. Notch-1 controls the expression of fatty acid-activated transcription factors and is required for adipogenesis. J Biol Chem. 1997;272(47):29729–29734
  90. Petit A, Bihel F, Alves da Costa C, et al. New protease inhibitors prevent γ-secretase-mediated production of Abeta40/42 without affecting Notch cleavage. Nat Cell Biol. 2001;3(5):507–511

PII: S0959-8049(05)00727-6

doi: 10.1016/j.ejca.2005.06.025

European Journal of Cancer
Volume 41, Issue 17 , Pages 2620-2629 , November 2005

Article Tools

* Image Usage & Resolution